Literature DB >> 9609010

[Natural history of myocardial hypertrophy and its association with hyperinsulinism in infants of diabetic mothers].

P Zielinsky1, M H da Costa, L T Oliveira, F P Bonow, N I da Silva, L L Hagemann.   

Abstract

PURPOSE: To test the hypothesis that myocardial hypertrophy is associated with increased serum insulin levels in children of diabetic mothers and to determine the frequency and timing of this spontaneous regression.
METHODS: Seventy-two patients were studied (54 children of diabetic mothers and 18 controls). Diagnosis of myocardial hypertrophy was made by fetal echocardiography. Amniotic fluid insulin levels were obtained from a previous prenatal study on hypertrophic cardiomyopathy, since the participation of the mothers was common to both projects.
RESULTS: There were 10 cases of myocardial hypertrophy among children of diabetic mothers (18.52%). Septal thickness was significantly different between the 2 groups (children of diabetic mothers and controls) in the evaluation performed at the age of 1 month (p = 0.04). Insulin levels were still increased in children of diabetic mothers until the age of 3 months. During this period insulin levels were significantly higher than those of controls (p = 0.003 and p = 0.001, at 1 and 3 months, respectively). The association between regression of ventricular septum thickness and the decrease of insulin levels occurred up to the age of 1 month.
CONCLUSION: There was spontaneous regression of ventricular septum thickness in children of diabetic mothers during the first 6 months of life. The association between hyperinsulinism and hypertrophic cardiomyopathy was present up to the first month of life.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9609010     DOI: 10.1590/s0066-782x1997001200005

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  5 in total

1.  Maternal Diabetes and Intrapartum Fetal Electrocardiogram.

Authors:  Beth A Plunkett; Steven J Weiner; George R Saade; Michael A Belfort; Sean C Blackwell; John M Thorp; Alan T N Tita; Russell S Miller; David S McKenna; Edward K S Chien; Dwight J Rouse; Yasser Y El-Sayed; Yoram Sorokin; Steve N Caritis
Journal:  Am J Perinatol       Date:  2022-04-05       Impact factor: 3.079

2.  Cardiomyopathy in offspring of pregestational diabetic mouse pregnancy.

Authors:  Daniel Dowling; Niamh Corrigan; Stephen Horgan; Chris J Watson; John Baugh; Paul Downey; Fionnuala M McAuliffe
Journal:  J Diabetes Res       Date:  2014-06-26       Impact factor: 4.011

Review 3.  The molecular mechanisms of offspring effects from obese pregnancy.

Authors:  Daniel Dowling; Fionnuala M McAuliffe
Journal:  Obes Facts       Date:  2013-04-04       Impact factor: 3.942

4.  Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis.

Authors:  A L Depla; L De Wit; T J Steenhuis; M G Slieker; D N Voormolen; P G Scheffer; R De Heus; B B Van Rijn; M N Bekker
Journal:  Ultrasound Obstet Gynecol       Date:  2021-04       Impact factor: 7.299

5.  Cardiomyopathy and cardiac function in fetuses and newborns of diabetic mothers.

Authors:  Maria Augusta Bogo; Julia S Pabis; Ana B Bonchoski; Dercília C Dos Santos; Tainá J F Pinto; Mona A Simões; Jean C Silva; Francisco C Pabis
Journal:  J Pediatr (Rio J)       Date:  2020-11-08       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.